On Innovations and Product Safety
The quality of products is the basis of its competitiveness in the market. Steady income of producer depends also on the index of a unique product on the market and innovativeness. However, in many cases these innovations do not have the necessary degree of security, the user runs the risk of not only lose money, but lose health and life. The subjects of our study are safety of innovation products and technologies in Russia, especially in drug production, and control over it. For these proposes we used economical, legislative and management approaches and system analysis. We have shown existing legislation in Russia does not meet the requirements of modern quality control, and public institutions representing the interests of the citizens do not have undue influence on the business and government. It increases violations to produce low-quality, ineffective products by businesses. We explore examples of conflicts of interest between consumers and producers in different countries and come to the conclusion that the insolvency of the existing system of quality control in the Russian Federation. Thus, despite the policy of economic transition on the ‘path of innovation,' the quality of life, in fact, does not occur. The question of the effectiveness and safety of the pharmaceutical industry is very important. Measures aimed at the identification and elimination of violations of prescription, are non-system, the population continues to suffer from negligence and crime series businesses. To overcome this problem, we propose a comprehensive mechanism to verify the quality and the elimination of violations in this sphere.